Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
Mar 14, 2017
| Erica Klinger
Seema Verma Approved as CMS Administrator - Let's Preserve and Strengthen Medicare and Medicaid Savings
Press Release
Mar 13, 2017
| Erica Klinger
AAM Applauds Nomination of Dr. Scott Gottlieb to Lead the Food and Drug Administration
Blog
Mar 10, 2017
| Erica Klinger
The Future of Biosimilars – An Atlantic Policy Briefing
Video
Feb 14, 2017
| Erica Klinger
Doug's Story - #medswithinreach
Video
Feb 14, 2017
| Erica Klinger
Accessible Medicines for Everyone - AAM
Video
Feb 14, 2017
| Erica Klinger
McKenzie's Story - #medswithinreach
Video
Feb 14, 2017
| Erica Klinger
Michelle's Story - #medswithinreach
Video
Feb 14, 2017
| Erica Klinger
Raeanne's Story – Savings from Generic Medicines
Video
Feb 14, 2017
| Erica Klinger
AAM - Your Generics & Biosimilars Industry
Press Release
Feb 14, 2017
| Rachel Schwartz
Generic and Biosimilars Manufacturers Launch New Brand & Campaign to Expand Access to Medicines
Press Release
Feb 10, 2017
| Rachel Schwartz
Statement by Chip Davis, President and CEO, AAM, Regarding the Confirmation of HHS Secretary Tom Price
Blog
Feb 8, 2017
| Erica Klinger
2016 AAM Annual Report
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action